iCAD to Participate in the Guggenheim MedTech Disruptors Summit

Rhea-AI Summary

NASHUA, N.H., Aug. 02, 2021 – iCAD, a leader in medical technology, announced participation in the Guggenheim MedTech Disruptors Summit. Michael Klein, Chairman and CEO, and Stacey Stevens, President, will engage in a fireside chat on August 10, 2021, at 10:00 AM Eastern Time. This event highlights iCAD's commitment to innovative cancer detection and therapy solutions. The company continues to lead advancements in medical technology from its Nashua, NH headquarters.

NASHUA, N.H., Aug. 02, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, and Stacey Stevens, President, will participate in a fireside chat at the Guggenheim MedTech Disruptors Summit, taking place virtually on August 9-10, 2021.

Fireside Chat Details
Date: August 10, 2021
Time: 10:00am Eastern Time

About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:
Media Inquiries:
Jessica Burns, iCAD  
+1-201-423-4492
jburns@icadmed.com

Investor Relations:
Jeremy Feffer, LifeSci Advisors
+ 1-212-915-2568
jeremy@lifesciadvisors.com

FAQ

What event will iCAD participate in on August 10, 2021?

iCAD will participate in the Guggenheim MedTech Disruptors Summit on August 10, 2021.

Who from iCAD will be speaking at the Guggenheim Summit?

Michael Klein, Chairman and CEO, and Stacey Stevens, President, will be speaking at the summit.

What time is iCAD's fireside chat at the summit?

The fireside chat is scheduled for 10:00 AM Eastern Time on August 10, 2021.

What does iCAD specialize in?

iCAD specializes in innovative cancer detection and therapy solutions.

Where is iCAD located?

iCAD is headquartered in Nashua, New Hampshire.